An Open-label Exploratory Study With Memantine: Correlation Between Proton Magnetic Resonance Spectroscopy, Cerebrospinal Fluid Biomarkers, and Cognition in Patients With Mild to Moderate Alzheimer's Disease.
Phase of Trial: Phase IV
Latest Information Update: 02 Mar 2016
At a glance
- Drugs Memantine (Primary)
- Indications Alzheimer's disease
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 01 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 May 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.